Consult
Log In
Menu
Consult
Log in
thr3-eyes-168518-unsplash-463127-edited
Mark McDonough

Mark McDonough

Chief Executive Officer

Mark McDonough is a global technology business executive with 30 years of experience, and he has been CEO of PierianDx since November 2020. His personal mission is to impact change in the field of healthcare in a compassionate yet resolute manner, leading by example.

Prior to PierianDx, Mark has served as President, CEO, and Board member for private companies like Immunis.AI, a pre-commercial liquid biopsy company, where he secured funding and developed a top flight team within six months of hire, and public companies like CombiMatrix, a leader in high complexity reproductive health testing. McDonough served as President, CEO and board member of CombiMatrix from 2012 through 2018, orchestrating its sale to Invitae in November 2017. Under his leadership, CombiMatrix experienced 14 consecutive quarters of record growth.

Earlier in his career, he served in various sales leadership roles at high growth diagnostic companies to include Ventana Medical Systems (acquired by Roche) and US LABS (acquired by LabCorp). He is married with three children and is a proud former Naval Officer having served as a Navigator and Communications Officer on the USS FLETCHER (DD 992).

I am excited to join PierianDx and lead this talented team committed to delivering tools to our partners and customers that enable precision medicine adoption at scale."